Gustavo Cumbo-Nacheli

Gustavo Cumbo-Nacheli practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health.

Gustavo Cumbo-Nacheli's NPI, 1013124312, was assigned on May 17, 2007. Gustavo Cumbo-Nacheli graduated from Universidad Nacional de Rosario Faculty of Medicine in 2003. Gustavo Cumbo-Nacheli holds Michigan license 4301086233.

Gustavo Cumbo-Nacheli's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth, at 100 Michigan St NE, Grand Rapids, MI 49503 in Kent County. The practice phone is (616) 391-1774.

Gustavo Cumbo-Nacheli's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health. Gustavo Cumbo-Nacheli is also affiliated with Bronson Methodist Hospital. The medical group on file is Corewell Health Medical Group West. Dmand AI also links Gustavo Cumbo-Nacheli to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gustavo Cumbo-Nacheli practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Gustavo Cumbo-Nacheli's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Gustavo Cumbo-Nacheli is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Gustavo Cumbo-Nacheli's licenses on file in 2 states: Michigan and Ohio.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), lung resection, pleural effusion and tobacco use among the conditions Gustavo Cumbo-Nacheli treats.

CMS data shows 218 Medicare services from Gustavo Cumbo-Nacheli across 11 procedure codes in 2024, for 151 Medicare patients. Medicare paid $20,331 for them.

CMS counts 151 Medicare patients who saw Gustavo Cumbo-Nacheli in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gustavo Cumbo-Nacheli's median patient age at 67, with 55% women.

In 2024, Gustavo Cumbo-Nacheli wrote 69 Medicare Part D claims for 32 patients. 78% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $490 in total drug cost. In 2023, CMS named 61 claims across 4 drugs.

Gustavo Cumbo-Nacheli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Gustavo Cumbo-Nacheli as offering telehealth.

Dmand AI links 15 papers to Gustavo Cumbo-Nacheli, published from 2012 to 2024. 2012 was the busiest year, with 2. The most frequent topics are Bronchoscopy, Robotic Surgical Procedures and Diagnosis, Differential. Gustavo Cumbo-Nacheli has published most often in J Bronchology Interv Pulmonol. Gustavo Cumbo-Nacheli's most frequent co-authors are Diego Ignacio Conci, MD, John P. Egan, MD and Robert James Lentz, MD.

Dmand AI links Gustavo Cumbo-Nacheli to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Bronchitis, Chronic, Lung Neoplasms and Pulmonary Disease, Chronic Obstructive.

CMS Open Payments shows 702 general payments to Gustavo Cumbo-Nacheli from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Ethicon Inc. paid the most, $385,805.

Dmand AI lists 1 award for Gustavo Cumbo-Nacheli, most recently CMS Stage 1 EHR in 2012.

Gustavo Cumbo-Nacheli graduated from Universidad Nacional de Rosario Faculty of Medicine in 2003. Gustavo Cumbo-Nacheli is a member of ACCP.

Gustavo Cumbo-Nacheli is in network with 15 carriers, including Aetna, Health Alliance Plan and Priority Health. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.